Northern Alliance Advanced Therapies Treatment Centre

The Northern Alliance Advanced Therapy Treatment Centre (NA-ATTC), formally established in March 2018, is a consortium of twenty industry, NHS and academic organisations led by Newcastle Hospitals and the Scottish National Blood Transfusion Service (SNBTS). The purpose of the centre is to develop the systems and infrastructure required to support the delivery of cell and gene therapies with the ultimate aim of increasing patient access to advanced therapy medicinal products (ATMPs) on a national level.

NA-ATTC’s vision is to increase patient access to advanced therapy medicinal products (ATMPs) regionally and nationally by growing a cost-effective clinical delivery pathway which meets the needs of the providers of advanced therapy products. The centre has a patient reach of circa 15 million spanning the North of England and Scotland and is working across two healthcare systems.

The centre will focus on all elements of the clinical delivery pathway from procurement of starting materials, near patient GMP, distribution and administration through to delivery of clinical trials and adoption and reimbursement across a range of advanced therapies and indications. This will entail the participation and collaboration of nurses, medical clinicians, hospital pharmacists, NHS managers, clinical commissioners and companies.

Please view our video which explains more about the NA-ATTC, our vision and how we plan to achieve this along with our Partners as well as our results so far:



The NA-ATTC works across the north of England (Leeds and Newcastle upon Tyne) and Scotland.

Our partners

Academic Health Science Network for the North East and North Cumbria (AHSN NENC)
Russ Watkins, Commercial Director

Donna Smith, Marketing

Achilles Therapeutics

Dr Shreenal Patel, SVP Clinical & Supply Chain Operations

Alcyomics Ltd
Professor Anne Dickinson, Founder and Director

Autolus Therapeutics

Christopher Vann Senior Vice President, Chief Operating Officer

Helen Delahaye, Project Manager

Chiesi Limited
Julie De-Almeida, Head of Market Access UK & Ireland
Tom Chubb, Rare Disease Manager


Dr John G Morris, Chief Executive Officer
Bill Shingleton, Alliances Manager

Julie Wright, Commercial Director
Jamie Pollard, Head of Software Development

Find out more about our work with Datatrial here.

Fisher Bioservices
Neil Ridley, Consultant Project Director
Luke Wilson, Lead Account Manager

Sandip Kumar, Project Manager, Client Services

NHS Greater Glasgow and Clyde
Dr David Irvine, Consultant Haematologist
Dr Samantha Carmichael, Lead Pharmacist – Clinical Trials/R&D
Melanie McColgan, General Manager, Specialist Oncology and Clinical Haematology

Leeds Teaching Hospitals NHS Trust
Dr Christopher Herbert, Director of Operations for Research and Innovation
Professor Gordon Cook, Professor of Haematology and Myeloma Studies
Dr Beki James, Consultant Paediatric Haematologist

Milteyni Biotec
Michele Giroux, UK General Manager

Newcastle University
Professor Jim Shaw, Professor of Regenerative Medicine
Professor Anne Dickinson, Strategic Research Adviser

Dr Mark Jarvis, Assistant Director of Pharmacy – Advanced Therapies

NHS Blood and Transplant
Jon Smythe, Head of Cellular and Molecular Therapies

Dr Sandeep Kumar, Cell Therapy Advanced Specialist

NHS Lothian
Professor Timothy Walsh, Head of Section/Lead of Edinburgh Critical Care Research Group, R&D Director – NHS Lothian

The Newcastle upon Tyne Hospitals NHS Foundation Trust
Neil Watson, Clinical Director of Pharmacy and Medicines Management and Co-Director of the NA-ATTC
Dr Finn Willingham, Operations Manager, NA-ATTC
David Caulfield, Assistant Director of Pharmacy, QA
Anne Black, Regional QA Specialist/Lead for Newcastle Therapeutics

pHion Therapeutics

Darach Neeson, Chief Operating Officer

Janet Downie, Chief Executive Officer

Scottish National Blood Transfusion Service
Professor Marc Turner, Medical Director SNBTS and Co-Director of the NA-ATTC
Professor John Campbell, Associate Director – Tissues, Cells and Advanced Therapeutics
Ewan Morrison, Director of Pharmacy, National Services Scotland

Sheffield Teaching Hospitals NHS Foundation Trust

Professor Simon Heller, R & D Director
Dr Dipak Patel, Research & Innovation Manager

Dr Matthew Lakelin, Chief Scientific Officer

Find out more about our work with TrakCel here.

University of Edinburgh
Prof Stuart Forbes, Director, Scottish Centre for Regenerative Medicine (SCRM), WP3 Co-Lead, Clinical Advisory Group Clinician Scientist Lead
Prof Andy Baker, Scientific Advisor
Lisa Wotherspoon, Advanced Therapies Clinical Trial Coordinator

University of Glasgow

Professor Stuart Nicklin, of Cardiovascular Molecular Therapy


Dr Christina O’Neill, Chief Executive Officer and Founder

Professor Alan Stitt, Scientific Consultant

Professor Reinhold Medina, Scientific  Consultant

World Courier
Kelly Frend , WEMEA Specialty Services Manager

Support was provided by Cell Medica ( for the first half of the project.

Leadership team

Professor Neil Watson, Clinical Director of Pharmacy and Medicines Optimisation and Co-Director of the NA-ATTC





Marc Turner, Co-Director






Finn Willingham, Operations Manager





Michael Whitaker, Steering Board Chair (Galen Biomed Ltd.)






Jim Shaw, Clinical Advisory Group Chair (Newcastle University)



Christopher Herbert, Leeds Teaching Hospitals NHS Foundation Trust






Andy Baker, Scientific Advisor (University of Edinburgh)







Christopher Vann, Senior Vice President, Chief Operating Officer, Autolus



Governance – Terms of Reference

The NA-ATTC is overseen by governance structures including a Steering Board, made up of representatives from each Partner Organisation, an Executive Team as detailed above, and a Clinical Advisory Group and Industry Advisory Group. Further details of these structures and their Terms of Reference are available below.

NA-ATTC Steering Board:

Steering Board

NA-ATTC Executive Team:

Executive Team

NA-ATTC Clinical Advisory Group:

Clinical Advisory Group

Clinical Advisory Group Membership

NA-ATTC Trial Coordination Unit

Trial Coordination Unit

Visit our other centres